NovaBay Pharmaceuticals, Inc. Capex/Depreciation

Capex/Depreciation of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex/Depreciation growth rates and interactive chart.


Highlights and Quick Summary

  • Capex/Depreciation for the quarter ending June 30, 2022 was -0.07 (a -66.36% decrease compared to previous quarter)
  • Year-over-year quarterly Capex/Depreciation decreased by -95.29%
  • Annual Capex/Depreciation for 2021 was -0.44 (a -14.28% decrease from previous year)
  • Annual Capex/Depreciation for 2020 was -0.51 (a 74.41% increase from previous year)
  • Annual Capex/Depreciation for 2019 was -0.29 (a 76.72% increase from previous year)
  • Twelve month Capex/Depreciation ending June 30, 2022 was -0.17 (a -24.09% decrease compared to previous quarter)
  • Twelve month trailing Capex/Depreciation decreased by -88.91% year-over-year
Trailing Capex/Depreciation for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
-0.17 -0.22 -0.44 -1.51
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex/Depreciation of NovaBay Pharmaceuticals, Inc.

Most recent Capex/Depreciationof NBY including historical data for past 10 years.

Interactive Chart of Capex/Depreciation of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Capex/Depreciation for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.07 -0.2
2021 -0.09 -1.42 -0.18 -2.78 -0.44
2020 -1.91 -0.42 0.0 0.0 -0.51
2019 0.0 0.0 -0.02 -0.82 -0.29
2018 -0.66 -0.09 -0.03 -0.05 -0.17
2017 -0.39 -4.06 -5.33 -3.28 -2.57
2016 -5.13 -1.29 -0.81 -0.4 -1.4
2015 -1.88 -0.59 -0.2 0.56 -0.52
2014 0.3 -0.8 1.31 -0.17 0.26
2013 -1.42 -0.06 -0.28 -0.11 -0.45
2012 -1.05 -0.61 -0.05 0.01 -0.42
2011 -0.02 0.0 -0.28

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology